A prospective non-randomised pilot clinical study to evaluate the safety, feasibility, and efficacy of MantraTM Surgical Robotic System, Model 3.0 in the predetermined surgical procedures. - NO

Sudhir Srivastava Innovations Pvt. Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•Male or Female patients with age of eighteen (18) and above.
•Able to give written informed consent.
•Patients meeting the inclusion criteria for one of the following surgical procedures using MantraTM Surgical Robotic System, Model 3.0 for soft tissue surgeries:
•Cholecystectomy
•Hysterectomy
•Nephrectomy
•Prostatectomy
•Oesophagus mobilization
•Internal Mammary Artery takedown
•Lung Lobectomy
•Nephron Sparing Surgery
•Bilateral Pelvic Lymph Node Dissection
•Radical Cystoprostatectomy
•Partial Nephrectomy

•Patients who have participated in another investigational clinical study within thirty (30) days before screening
•Inability to provide informed consent
•Uncontrolled Comorbidities such as hypertension, diabetes mellitus or any other co-morbidities that is considered as a high risk for the planned surgical procedure
•Patients who fall into New York Heart Association (NYHA) Class III or IV
•History of chronic alcohol or drug abuse.
•Chronic renal failure or on dialysis.
•Subjects with any other clinically significant unstable medical condition, life-threatening disease, or anything else in the opinion of the Investigator that would contra-indicate a surgical procedure.

发起方

Sudhir Srivastava Innovations Pvt. Ltd